Skip to main content

OrbiMed Advisors LLC's Form 4 filing

Compass Therapeutics, Inc.CMPX · filed May 10, 2022

Accession no.
0000947871-22-000540
Filed
May 10, 2022, 6:21 PM ET
Trade date
May 6-10, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions. Open-market purchases total $197.3K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
OrbiMed Advisors LLCCIK 0001055951Director, 10% Owner
OrbiMed Capital GP V LLCCIK 0001615374Director, 10% Owner
OrbiMed Genesis GP LLCCIK 0001808744Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 6, 2022Common StockPPurchaseAcquired+10,200$1.63F1+$16,62614,510,319IndirectDuplicate filing
May 9, 2022Common StockPPurchaseAcquired+90,712$1.56F2+$141,510.7214,601,031IndirectDuplicate filing
May 10, 2022Common StockPPurchaseAcquired+24,447$1.60F3+$39,115.214,625,478IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

These shares of the Issuer's common stock ("Shares") were purchased in a block at a price of $1.63.

Referenced by the price of 1 transaction in Table I.

F2

These Shares were purchased in a block at a price of $1.56.

Referenced by the price of 1 transaction in Table I.

F3

These Shares were purchased in a block at a price of $1.60.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)